Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Population Health Metrics
Published in: Population Health Metrics 1/2009

Open Access 01-12-2009 | Research

The burden of disease and injury in Iran 2003

Authors: Mohsen Naghavi, Farid Abolhassani, Farshad Pourmalek, Maziar Moradi Lakeh, Nahid Jafari, Sanaz Vaseghi, Niloufar Mahdavi Hezaveh, Hossein Kazemeini

Published in: Population Health Metrics | Issue 1/2009

Login to get access

Abstract

Background

The objective of this study was to estimate the burden of disease and injury in Iran for the year 2003, using Disability-Adjusted Life Years (DALYs) at the national level and for six selected provinces.

Methods

Methods developed by the World Health Organization for National Burden of Disease (NBD) studies were applied to estimate disease and injury incidence for the calculation of Years of Life Lost due to premature mortality (YLL), Years Lived with Disability (YLD), and DALYs. The following adjustments of the NBD methodology were made in this study: a revised list with 213 disease and injury causes, development of new and more specific disease modeling templates for cancers and injuries, and adjustment for dependent comorbidity. We compared the results with World Health Organization (WHO) estimates for Eastern Mediterranean Region, sub-region B in 2002.

Results

We estimated that in the year 2003, there were 21,572 DALYs due to all diseases and injuries per 100,000 Iranian people of all ages and both sexes. From this total number of DALYs, 62% were due to disability premature deaths (YLD) and 38% were due to premature deaths (YLL); 58% were due to noncommunicable diseases, 28% – to injuries, and 14% – to communicable, maternal, perinatal, and nutritional conditions. Fifty-three percent of the total number of 14.349 million DALYs in Iran were in males, with 36.5% of the total due to intentional and unintentional injuries, 15% due to mental and behavioral disorders, and 10% due to circulatory system diseases; and 47% of DALYs were in females, with 18% of the total due to mental and behavioral disorders, 18% due to intentional and unintentional injuries, and 12% due to circulatory system diseases. The disease and injury causes leading to the highest number of DALYs in males were road traffic accidents (1.071 million), natural disasters (548 thousand), opioid use (510 thousand), and ischemic heart disease (434 thousand). The leading causes of DALYs in females were ischemic heart disease (438 thousand), major depressive disorder (420 thousand), natural disasters (419 thousand), and road traffic accidents (235 thousand). The burden of disease at the province level showed marked variability. DALY estimates by Iran's NBD study were higher than those for EMR-B by WHO.

Conclusion

The health and disease profile in Iran has made the transition from the dominance of communicable diseases to that of noncommunicable diseases and road traffic injuries. NBD results are to be used in health program planning, research, and resource allocation and generation policies and practices.
Appendix
Available only for authorised users
Literature
1.
Mathers C, Lopez A, Salomon J, Ezzati M: National Burden of Disease Studies: A Practical Guide. Geneva: World Health Organization; 2001.
2.
President Deputy Offices for Strategic Planning and Supervision: Law of the Fourth Economic, Social, and Cultural Development Plan of the Islamic Republic of Iran, 2005–2009. Tehran 2004.
3.
Ministry of Health and Medical Education, Health Deputy: Burden of Diseases and Injuries, Burden of Risk Factors, and Health-Adjusted Life Expectancy in I. R. Iran for Year 2003 at National Level and for Six Provinces. Tehran 2007.
4.
Murray C, Evans D: Health Systems Performance Assessment: Debates, Methods and Empiricism. Geneva: World Health Organization; 2003.
5.
Hosseinpoor AR, Van Doorslaer E, Speybroeck N, Naghavi M, Mohammad K, Majdzadeh R, Delavar B, Jamshidi H, Vega J: Decomposing socioeconomic inequality in infant mortality in Iran. Int J Epidemiol 2006,35(5):1211-9. 10.1093/ije/dyl164CrossRefPubMed
6.
World Health Organization: International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. Geneva 1992.
7.
Mathers C, Boschi-Pinto C, Lopez A, Murray CL: Cancer incidence, mortality and survival by site for 14 regions of the world. Geneva: World Health Organization; 2001.
8.
Naghavi M, Jafari N, Alaeddini F, Akbari ME: Epidemiology of injuries due to external causes in Iran. Tehran: Ministry of Health and Medical Education; 2003.
9.
Murray C, Lopez A: The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard School of Public Health on behalf of WHO; 1996. [Murray C, Lopez A (Series Editors):Global Burden of Disease and Injury Series, vol 1.]
10.
Mathers C, Vos T, Stevenson C: The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare; 1999 AIHW cat. no. PHE 17;
11.
Stouthard M, Essink-Bot M, Bonsel G, on behalf of the Dutch Disability Weights Group: Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health 2000, (10):24-30. 10.1093/eurpub/10.1.24
12.
Adler M, Ziglio E: Gazing into the Oracle: The Delphi Method and its Applications to Social Policy and Public Health. London: Jessica Kingsley; 1996.
13.
Naghavi M: Profile of Death in 23 Provinces of Iran in Year 2003. Tehran: Ministry of Health and Medical Education; 2005.
14.
Lopez A, Mathers C, Ezzati M, Jamison D, Murray C: Global Burden of Disease and Risk Factors. Washington: Oxford University Press and The World Bank; 2006.CrossRef
15.
Regional Health Systems Observatory, EMRO, WHO: Health System Profile of Islamic Republic of Iran. Cairo 2006.
16.
Barendregt J, van Oortmarssen J, Vos T, Murray C: A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr. 2003,1(1):4. 10.1186/1478-7954-1-4CrossRefPubMedPubMedCentral
17.
Ministry of Health and Medical Education, Center for Disease Management: Cancer Registry Annual Report 2003. Tehran 2004.
18.
Naghavi M, Jamshidi HR: Utilization of Health Services in I. R. Iran in year 2002. Tehran 2006.
19.
Mohammad K, Noorbala A: Study of Health and Disease in Iran. Tehran: Ministry of Health and Medical Education; 2001.
20.
Ministry of Health and Medical Education, in collaboration with Statistical Center of Iran, Civil Registration Organization of Iran, United Nations Children's Fund (UNICEF), and United Nations Population Fund (UNFPA): Profile of Population and Health, Demographic and Health Survey (DHS). Tehran. 2000.
21.
Ministry of Health and Medical Education: Profile of Child Nutrition in Provinces. Tehran 1998.
22.
Ministry of Health and Medical Education: National Study of Micronutrients. Tehran 2001.
23.
Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, Yazdi SA, Rahgozar M, Alaghebandrad J, Amini H, Razzaghi EM, Mesgarpour B, Soori H, Mohammadi M, Ghanizadeh A: An epidemiological survey of psychiatric disorders in Iran. Clin Pract Epidemol Ment Health 2005, 1: 16. 10.1186/1745-0179-1-16CrossRef
24.
Yasami M, Shahmohammadi D, Naghavi M: Epidemiologic Study of Drug Abuse in Iran. Tehran: Ministry of Health and Medical Education; 2003.
25.
Delavar B, Azemikhah A, Eslami M: Integrated Monitoring and Evaluation System for Reproductive Health Programs. Tehran: Ministry of Health and Medical Education; 2005.
26.
Tehran University of Medical Sciences: Community Oriented Program for Control of Rheumatic Diseases (COPCORD). Tehran 2001.
27.
Isfahan University of Medical Sciences: Isfahan Healthy Heart Study. Isfahan 2003.
28.
Hormozgan University of Medical Sciences: Persian Gulf Healthy Heart Study. Bushehr 2001.
29.
Fotouhi A, Hashemi M, Mohammad K, Jalali K: The prevalence and causes of visual impairment in Tehran: The Tehran Eye Study. Br J Ophthalmol 2004,88(6):740-745. 10.1136/bjo.2003.031153CrossRefPubMedPubMedCentral
30.
31.
Naghavi M, Jafari N, Jamshidbeigy E, Vasegh H, Azad A, Akbari ME: Health Profile Transition in Rural Areas of Iran. Tehran: Ministry of Health and Medical Education; 2005.
32.
Naghavi M: Health transition in Iran. Iranian Journal of Epidemiology 2006,1(3):13-25.
33.
Khosravi A, Taylor R, Naghavi M, Lopez AD: Mortality in the Islamic Republic of Iran, 1964–2004. Bull World Health Organ 2007,85(8):607-14. 10.2471/BLT.06.038802CrossRefPubMedPubMedCentral
34.
Naghavi M: Profile of Death in 29 Provinces of Iran in Year 2004. Tehran: Ministry of Health and Medical Education; 2007.
35.
Ministry of Health and Medical Education: Annual Report of the National Death Registry System to World Health Organization, 2005. Tehran 2007.
Metadata
Title
The burden of disease and injury in Iran 2003
Authors
Mohsen Naghavi
Farid Abolhassani
Farshad Pourmalek
Maziar Moradi Lakeh
Nahid Jafari
Sanaz Vaseghi
Niloufar Mahdavi Hezaveh
Hossein Kazemeini
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Population Health Metrics / Issue 1/2009
Electronic ISSN: 1478-7954
DOI
https://doi.org/10.1186/1478-7954-7-9

Other articles of this Issue 1/2009

Population Health Metrics 1/2009 Go to the issue

Research

Mortality attributable to excess adiposity in England and Wales in 2003 and 2015: explorations with a spreadsheet implementation of the Comparative Risk Assessment methodology

Research

Validity of self-reported weight, height, and body mass index among university students in Thailand: Implications for population studies of obesity in developing countries

Research

Further validation of the Multidimensional Fatigue Inventory in a US adult population sample

Research

Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue

Research

Calculation of health expectancies with administrative data for North Rhine-Westphalia, a Federal State of Germany, 1999–2005

Research

Diabetes prevalence and diagnosis in US states: analysis of health surveys